Schroder UK-Listed Equity Income Maximiser Fund Q1 GBP AccRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | 18.4 | 6.3 | 7.2 | 6.9 | |
+/-Cat | - | 0.6 | 9.7 | 0.5 | -0.3 | |
+/-B’mrk | - | - | - | -0.4 | -1.3 | |
Category: UK Equity Income | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 22/11/2024 | GBP 0.72 | |
Day Change | 1.15% | |
Morningstar Category™ | UK Equity Income | |
IA (formerly IMA) Sector | UK Equity Income | |
ISIN | GB00BF781756 | |
Fund Size (Mil) 05/11/2024 | GBP 63.11 | |
Share Class Size (Mil) 22/11/2024 | GBP 0.00 | |
Max Initial Charge | - | |
Ongoing Charge 14/10/2024 | 0.25% |
Investment Objective: Schroder UK-Listed Equity Income Maximiser Fund Q1 GBP Acc |
The Fund aims to provide income by investing in equity and equity related securities of large UK companies. The Fund aims to deliver an income of 7% per year but this is not guaranteed and could change depending on market conditions. The Fund invests at least 80% of its assets in a passively managed portfolio from the top 100 listed UK companies by market capitalisation. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Jeegar Jagani 04/12/2020 | ||
Scott Thomson 04/12/2020 | ||
Click here to see others | ||
Inception Date 04/12/2020 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE 100 NR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Schroder UK-Listed Equity Income Maximiser Fund Q1 GBP Acc | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 8.12 |
Shell PLC | Energy | 7.79 |
HSBC Holdings PLC | Financial Services | 6.50 |
Unilever PLC | Consumer Defensive | 5.72 |
RELX PLC | Industrials | 3.33 |
Increase Decrease New since last portfolio | ||
Schroder UK-Listed Equity Income Maximiser Fund Q1 GBP Acc |